Regression analysis of the risk factors for postoperative nosocomial infection in patients with abdominal tumors: experience from a large cancer centre in China

  • Sun Zhipeng
    Oncology Surgery Department, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University)
  • Zhu Yubing
    Oncology Surgery Department, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University)
  • Xu Guangzhong
    Oncology Surgery Department, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University)
  • Aminbuhe
    Oncology Surgery Department, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University)
  • Zhang Nengwei
    Oncology Surgery Department, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University)

この論文をさがす

抄録

Nosocomial infection is a common complication after abdominal oncology surgery. Aimed at finding its independent risk factors for prevention, all the patients who underwent abdominal oncology surgery were summarized from March 1st, 2010 to March 1st, 2013 from the oncology surgery department, Beijing Shijitan Hospital. The investigated variances were patients’ information including admission number, sex, age, diabetes, diagnosis, length of stay, American society of anesthesiologists (ASA) grade, surgery time, number of drainage tubes. Comparisons were taken between the infected cases and non-infected cases for retrospective logistic regression analysis. 4 variances including diabetes, preoperative hospitalization time ≥ 6 days, surgery time ≥ 230 minutes, ASA grade ≥ III were found out to be related to nosocomial infection after surgery. The 4 variances mentioned above were risk factors for nosocomial infection after surgery.

収録刊行物

  • Drug Discoveries & Therapeutics

    Drug Discoveries & Therapeutics 9 (6), 411-416, 2015

    特定非営利活動法人 バイオ&ソーシャル・サイエンス推進国際研究交流会

参考文献 (19)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ